FDA UDI In Commercial Distribution 🇺🇸 United States

OVA1

DI: 00860942000113 · Model: 3.0.3.006 · Aspira Women's Health Inc.
Product Codes
1
GMDN Terms
1
Identifiers
1
Pkg Device Count
1

Basic Information

Brand Name
OVA1
Primary DI
00860942000113
Version / Model
3.0.3.006
Company Name
Aspira Women's Health Inc.
Labeler DUNS
861471498
Distribution Status
In Commercial Distribution
Device Count in Pkg
1
Record Status
Published
Publish Date
2018-01-15
Public Version
6
Public Version Date
2023-07-26
Public Version Status
Update
Public Device Record Key
450cd9c2-9e55-4202-a897-a6eade535939

Device Description

Ova1® is a qualitative serum test that combines the results of five immunoassays into a single numerical result. It is indicated for women who meet the following criteria: over age 18, ovarian adnexal mass present for which surgery is planned, and not yet referred to an oncologist. Ova1® is an aid to further assess the likelihood that malignancy is present when the physician’s independent clinical and radiological evaluation does not indicate malignancy. The test is not intended as a screening or stand-alone diagnostic assay.

Device Characteristics

Single Use
No
Prescription Use (Rx)
Yes
Over the Counter (OTC)
No
Kit
No
Combination Product
No
HCT/P
No
Contains NRL
No
Not Made with NRL
No
MRI Safety
Labeling does not contain MRI Safety Information
Direct Marking Exempt
No
PM Exempt
No
Has Serial Number
No
Has Lot/Batch Number
No
Has Manufacturing Date
No
Has Expiration Date
No
Has Donation ID
No

Sterilization

Is Sterile
No
Sterilization Prior Use
No

Product Codes

Code Name
ONX Ovarian Adnexal Mass Assessment Score Test System

GMDN Terms

Code Name
57967 Medical equipment clinical data interfacing software

Identifiers

Type ID
Primary 00860942000113

Customer Contacts

Phone
844.277.4721

Premarket Submissions

Submission Number Supplement Number
DEN090004 000